EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Impact of Nintedanib and Anti-Angiogenic Agents on Uveal Melanoma Cell Behavior

Vera E Pawlik, Svenja R Sonntag, Salvatore Grisanti, Aysegül Tura, Vinodh Kakkassery, Mahdy Ranjbar

Investigative Opthalmology & Visual Science · 21.02.2024 · 65 (2) · 30

DOI: 10.1167/iovs.65.2.30 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Investigative Opthalmology & Visual Science, erschienen am 21.02.2024. Verfasst von Vera E Pawlik und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, University of Lübeck, Lübeck, Germany. Hauptthemen laut MEDLINE: Vascular Endothelial Growth Factor A, Uveal Neoplasms, Indoles, Melanoma. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 155 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

The purpose of this study was to investigate the direct impact of the combined angiokinase inhibitor nintedanib as well as the anti-angiogenic agents ranibizumab, bevacizumab, and aflibercept on the primary uveal melanoma (UM) cell line Mel270 and liver metastasis UM cell line OMM2.5.

Methods

The metabolic activity, viability, and oxidative stress levels were analyzed by the Thiazolyl Blue Tetrazolium Bromide (MTT), LIVE/DEAD, and reactive oxygen species (ROS) assays. Expression of intracellular VEGF-A165 and VEGF receptor-2 was detected by immunofluorescent staining. The secretion of VEGF-A165 into the cell culture supernatants was evaluated by VEGF-A165 ELISA.

Results

Nintedanib, at a concentration of 1 µg/mL, resulted in a median reduction of metabolic activity (for Mel270 of approximately 38% and for OMM2.5 of 46% compared to the untreated control) without exerting toxicity in either cell line, whereas the other 3 substances did not result in any changes (which also means that none of the 4 substances led to an increased cell death). Moreover, nintedanib (1 µg/mL) induced oxidative stress in the Mel270 by approximately 1.2 to 1.5-fold compared to the untreated control, but not the OMM2.5 cells.

Conclusions

Nintedanib could suppress the growth of UM cells in a concentration-dependent manner. The metastatic UM cell line OMM2.5 was not sensitive to the pro-oxidant activity of nintedanib. This study was the first to investigate nintedanib in the context of UM. We propose further investigation of this substance to elucidate its effects on this tumor entity with the hope of identifying advantageous therapeutic options for future adjuvant tumor therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vascular Endothelial Growth Factor AUveal NeoplasmsIndolesMelanomaHumansAngiogenesis InhibitorsUveal Melanoma

Substanzen

nintedanibVascular Endothelial Growth Factor AAngiogenesis InhibitorsIndoles

Autor:innen und Institutionen

  • Department of Ophthalmology, University of Lübeck, Lübeck, Germany.

Zitieren

APA

Pawlik, V. E., Sonntag, S. R., Grisanti, S., Tura, A., Kakkassery, V., & Ranjbar, M. (2024). Impact of Nintedanib and Anti-Angiogenic Agents on Uveal Melanoma Cell Behavior. Investigative Opthalmology & Visual Science, 65(2), 30. https://doi.org/10.1167/iovs.65.2.30

Vancouver

Pawlik VE, Sonntag SR, Grisanti S, Tura A, Kakkassery V, Ranjbar M. Impact of Nintedanib and Anti-Angiogenic Agents on Uveal Melanoma Cell Behavior. Investigative Opthalmology & Visual Science. 2024;65(2):30. doi:10.1167/iovs.65.2.30

BibTeX
@article{Pawlik2024,
  author = {Pawlik, Vera E and Sonntag, Svenja R and Grisanti, Salvatore and Tura, Aysegül and Kakkassery, Vinodh and Ranjbar, Mahdy},
  title = {Impact of Nintedanib and Anti-Angiogenic Agents on Uveal Melanoma Cell Behavior},
  journal = {Investigative Opthalmology & Visual Science},
  year = {2024},
  volume = {65},
  number = {2},
  pages = {30},
  doi = {10.1167/iovs.65.2.30}
}
Kostenlos starten →